Physician profile
W D Craske
NPI 1922089390
$2,558.62
in general payments reported to CMS, 2019-2025
15 companies · $91.53 in 2025
The $91.53 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.46 · 2020: $1,009 · 2021: $273 · 2022: $105 · 2023: $316 · 2024: $682 · 2025: $91.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,090.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,089.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,008.74 | 2020 | |
| Medtronic, INC. | $758.60 | 2021-2025 | Hawkone, Abre, In.Pact Admiral |
| W. L. Gore & Associates, INC. | $220.86 | 2022-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Excluder Aaa Endoprosthesis |
| Silk Road Medical, INC. | $195.77 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Bolton Medical INC | $148.01 | 2023 | Treo Abdominal Stent-Graft System |
| Astellas Pharma US INC | $46.40 | 2019 | |
| Aroa Biosurgery Incorporated | $35.06 | 2019 | |
| Haemonetics Corporation | $33.31 | 2024 | Teg6s Hemostasis System |
| Baxter Healthcare | $21.90 | 2021 | |
| Novartis Pharmaceuticals Corporation | $20.66 | 2024 | |
| Solventum Corporation | $19.20 | 2024 | Prevena, Abthera, 3m Cavilon |
| Actelion Pharmaceuticals US, INC. | $16.72 | 2024 | Opsumit, Uptravi |
| Novo Nordisk INC | $16.17 | 2023 | Wegovy |
| Kci USA, INC. | $13.90 | 2023 | V.A.C. Veraflo Cleanse Choice, Activ.A.C., Prevena |
| Ets Wound Care LLC | $3.32 | 2025 | Mirragen Advanced Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw W Craske listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.